These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33792440)

  • 21. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Pyke RE; Clayton AH
    J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine aspects of female sexual dysfunction.
    Davis SR; Guay AT; Shifren JL; Mazer NA
    J Sex Med; 2004 Jul; 1(1):82-6. PubMed ID: 16422987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
    Kingsberg SA; Simon JA
    J Womens Health (Larchmt); 2020 Aug; 29(8):1101-1112. PubMed ID: 32460605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and Management of Hypoactive Sexual Desire Disorder.
    Clayton AH; Kingsberg SA; Goldstein I
    Sex Med; 2018 Jun; 6(2):59-74. PubMed ID: 29523488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
    Kingsberg SA; Althof SE
    J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
    Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
    J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I; Simon JA
    Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
    Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
    Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of testosterone therapy in women.
    Al-Imari L; Wolfman WL
    J Obstet Gynaecol Can; 2012 Sep; 34(9):859-865. PubMed ID: 22971455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.
    Warnock JK; Clayton A; Croft H; Segraves R; Biggs FC
    J Sex Med; 2006 Sep; 3(5):878-882. PubMed ID: 16942531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testosterone therapy in female hypoactive sexual desire disorder].
    Meyer P
    Rev Med Suisse; 2016 Mar; 12(510):540-3. PubMed ID: 27149714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopause and sexual desire: the role of testosterone.
    Nappi RE; Albani F; Santamaria V; Tonani S; Martini E; Terreno E; Brambilla E; Polatti F
    Menopause Int; 2010 Dec; 16(4):162-8. PubMed ID: 21156854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).
    Leiblum SR; Koochaki PE; Rodenberg CA; Barton IP; Rosen RC
    Menopause; 2006; 13(1):46-56. PubMed ID: 16607098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone use in postmenopausal women.
    Martínez-García A; Davis SR
    Climacteric; 2021 Feb; 24(1):46-50. PubMed ID: 32705895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women.
    Palacios S
    Womens Health (Lond); 2011 Jan; 7(1):95-107. PubMed ID: 21175394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder.
    Simon JA; Athavale A; Ravindranath R; Hadker N; Sadiq A; Lim-Watson M; Williams L; Krop J
    J Womens Health (Larchmt); 2022 May; 31(5):715-725. PubMed ID: 35475708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.